Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM (PODER)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01457066|
Recruitment Status : Completed
First Posted : October 21, 2011
Last Update Posted : May 27, 2015
|Condition or disease||Intervention/treatment||Phase|
|HIV||Behavioral: Peer Navigator Intervention||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||118 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM|
|Study Start Date :||December 2012|
|Primary Completion Date :||June 2014|
|Study Completion Date :||September 2014|
This group will receive the peer navigator intervention.
Behavioral: Peer Navigator Intervention
Peer navigators will teach HIV retention and linkage skills and knowledge using group-based as well as one-on-one, peer-based learning approaches.
No Intervention: Control
This group will receive usual care.
- Retention in care [ Time Frame: Six month follow up ]Retention in care will be assessed through the following measures: HIV medical care visits, ART use, self-reported adherence, acute care utilization, viral load, and health-related quality of life
- Intermediate outcome variables [ Time Frame: Six month follow up ]Social support, perceived social norms, retention knowledge, retention self-efficacy, outcome expectations
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01457066
|United States, California|
|Los Angeles, California, United States, 90023|
|Principal Investigator:||William E Cunningham, MD, MPH||University of California, Los Angeles|